This effect provides evidence for a link between clinical efficacy of methylphenidate and status of the human NK1R analog gene, TACR1 [45] — an important finding given the high rate of non-response to this treatment amongst ADHD patients [49]. Here, TACR1 is linked to attention deficit-hyperactivity disorder.